BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24636817)

  • 1. FDA's proposed ban on trans fats: How do the costs and benefits stack up?
    Cohen JT
    Clin Ther; 2014 Mar; 36(3):322-7. PubMed ID: 24636817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First time compliance inspections to evaluate an artificial trans fat ban in Nassau County.
    Sood RK; Torroella Carney M; Buchman T; Cabello CS; Lynch JF; Frank SH; Trapl ES
    Clin Ther; 2014 Mar; 36(3):333-7.e1. PubMed ID: 24636819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for banning trans fats. The FDA's new policy on these deadly artificial fatty acids is long overdue.
    Willett W
    Sci Am; 2014 Mar; 310(3):13. PubMed ID: 24660319
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of local, state, and national government legislation restricting trans fats.
    Assaf RR
    Clin Ther; 2014 Mar; 36(3):328-32. PubMed ID: 24636818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.
    Allen K; Pearson-Stuttard J; Hooton W; Diggle P; Capewell S; O'Flaherty M
    BMJ; 2015 Sep; 351():h4583. PubMed ID: 26374614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Demise of Artificial Trans Fat: A History of a Public Health Achievement.
    Amico A; Wootan MG; Jacobson MF; Leung C; Willett AW
    Milbank Q; 2021 Sep; 99(3):746-770. PubMed ID: 34342900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans fats in America: a review of their use, consumption, health implications, and regulation.
    Remig V; Franklin B; Margolis S; Kostas G; Nece T; Street JC
    J Am Diet Assoc; 2010 Apr; 110(4):585-92. PubMed ID: 20338284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
    Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
    Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US moves to ban trans fats.
    McCarthy M
    BMJ; 2013 Nov; 347():f6749. PubMed ID: 24212566
    [No Abstract]   [Full Text] [Related]  

  • 11. The trans-fat ban--food regulation and long-term health.
    Brownell KD; Pomeranz JL
    N Engl J Med; 2014 May; 370(19):1773-5. PubMed ID: 24806156
    [No Abstract]   [Full Text] [Related]  

  • 12. New and existing oils and fats used in products with reduced trans-fatty acid content.
    Tarrago-Trani MT; Phillips KM; Lemar LE; Holden JM
    J Am Diet Assoc; 2006 Jun; 106(6):867-80. PubMed ID: 16720128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group.
    Eckel RH; Borra S; Lichtenstein AH; Yin-Piazza SY;
    Circulation; 2007 Apr; 115(16):2231-46. PubMed ID: 17426064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safer fats for healthier hearts: the case for eliminating dietary artificial trans fat intake.
    Gerberding JL
    Ann Intern Med; 2009 Jul; 151(2):137-8. PubMed ID: 19620167
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study.
    Pearson-Stuttard J; Hooton W; Critchley J; Capewell S; Collins M; Mason H; Guzman-Castillo M; O'Flaherty M
    J Public Health (Oxf); 2017 Sep; 39(3):574-582. PubMed ID: 27613767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removing industrial trans fat from foods.
    Mozaffarian D; Stampfer MJ
    BMJ; 2010 Apr; 340():c1826. PubMed ID: 20395265
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterol control beyond the clinic: New York City's trans fat restriction.
    Angell SY; Silver LD; Goldstein GP; Johnson CM; Deitcher DR; Frieden TR; Bassett MT
    Ann Intern Med; 2009 Jul; 151(2):129-34. PubMed ID: 19620165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans fats: chasing a global ban.
    Coombes R
    BMJ; 2011 Sep; 343():d5567. PubMed ID: 21900347
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatty acid composition including trans-fatty acids in edible oils and fats: probable intake in Indian population.
    Dixit S; Das M
    J Food Sci; 2012 Oct; 77(10):T188-99. PubMed ID: 22950538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labeling of trans fatty acid content in food, regulations and limits-the FDA view.
    Moss J
    Atheroscler Suppl; 2006 May; 7(2):57-9. PubMed ID: 16713387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.